IRadimed Corporation (NASDAQ: IRMD) develops, manufactures, and markets innovative MRI compatible medical devices. We are the only known provider of non-magnetic intravenous (IV) infusion pump systems and non-magnetic patient vital signs monitors specifically designed for use during magnetic resonance imaging (MRI) procedures. IRadimed was founded in 2005 and became public in 2014 and currently holds leading market positions across the globe. This growth minded company is headquartered in Winter Springs, Florida.



Latest Filings

Latest Quarterly Filing

10-Q

08/04/2017


Latest Annual Filing

10-K

03/10/2017


Latest Current Report

8-K

07/28/2017


Latest Proxy Statement

DEF 14A

04/28/2017


To access the entire IRadimed SEC Filings archive please click the following link: